The Trump administration says pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs after months of negotiations and that it's expected to produce billions in savings for older adults. But the net prices unveiled Tuesday aren't what Medicare recipients will pay at their pharmacy counters because those final amounts will depend on each individual's plan and how much they spend annually on prescriptions. Health Secretary Robert F. Kennedy Jr. touted the deals as part of efforts to address affordability concerns. The negotiation program is mandated by law and began under the Biden administration.

A coalition of nursing and other health care organizations are pushing back against a Trump administration plan that could limit access to student loans in some cases. Students pursuing graduate degrees in nursing, physical therapy and some other fields would face tighter federal student loan limits under the plan because it doesn't consider them professional programs. The revamp is part of an overhaul passed by Congress in Trump's "Big Beautiful Bill." Under current rules, graduate students can borrow loans up to the cost of their degree. But the new rules would set caps depending on whether the degree is considered a graduate or professional program. The Trump administration believes the changes could reduce tuition costs.